Altimmune Inc. (ALT)
NASDAQ: ALT
· Real-Time Price · USD
3.56
-0.07 (-1.93%)
At close: Aug 21, 2025, 11:26 AM
Altimmune Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 20K | 20K | 20K | 52K | 409K | 410K | 426K | 279K | -81K | -79K | -68K | 3.32M | 3.48M | 3.6M | 4.41M | 3.45M | 6.23M | 6.81M |
Cost of Revenue | 67K | 98K | 205K | 2.1M | 20.45M | 20.39M | 19.92M | 18.14M | 20.02M | 36.01M | 36.48M | 57.42M | 66.36M | 63.64M | 74.52M | 68.48M | 56.32M | 59.64M |
Gross Profit | -10K | 20K | -87K | -1.95M | -19.98M | -33.23M | -32.75M | -31.12M | -33.35M | -36.09M | -36.55M | -54.1M | -62.89M | -60.04M | -70.11M | -65.04M | -50.09M | -52.83M |
Operating Income | -94.37M | -98.19M | -103.17M | -111.93M | -109.7M | -100.96M | -95.93M | -85.4M | -87.61M | -90M | -87.74M | -88.63M | -97.08M | -101.55M | -96.91M | -83.68M | -68.8M | -62.35M |
Interest Income | 6.16M | 7.21M | 8.07M | 8.47M | 8.44M | 8.1M | 7.35M | 7.04M | 6.21M | 4.7M | 3.05M | 1.58M | 538K | 243K | 264K | 132.36K | 164.49K | 212.94K |
Pretax Income | -88.43M | -90.92M | -95.06M | -103.52M | -101.35M | -92.77M | -88.45M | -78.47M | -81.51M | -85.55M | -84.91M | -87.14M | -96.94M | -101.66M | -97.09M | -83.93M | -68.68M | -62.19M |
Net Income | -87.75M | -90.24M | -95.06M | -103.52M | -101.35M | -92.77M | -86.76M | -75.35M | -78.19M | -82.24M | -83.21M | -86.87M | -96.87M | -101.59M | -97.09M | -83.82M | -68.08M | -60.02M |
Selling & General & Admin | 21.74M | 21.65M | 20.97M | 20.21M | 19.75M | 18.92M | 18.14M | 17.61M | 17.59M | 17.24M | 17.13M | 17.11M | 16.77M | 16.02M | 15.41M | 15.75M | 15.81M | 14.7M |
Research & Development | 72.65M | 76.57M | 82.23M | 79.35M | 77.94M | 70.04M | 65.8M | 68.07M | 69.94M | 72.68M | 70.54M | 71.54M | 80.49M | 77.77M | 74.54M | 63.31M | 51.14M | 54.46M |
Other Expenses | n/a | n/a | -107K | -2M | -2M | -2M | -1.87M | -198K | -148K | -123K | -32K | 104.36K | -231.83K | -230.74K | -373.87K | -317.97K | -2.55K | -34.53K |
Operating Expenses | 94.39M | 98.21M | 103.08M | 97.56M | 95.69M | 86.96M | 82.05M | 85.68M | 87.53M | 89.92M | 87.67M | 88.65M | 97.26M | 93.79M | 89.95M | 79.05M | 66.96M | 69.16M |
Interest Expense | 272K | 9K | 9K | 10K | 33K | 34K | 35K | 33K | 68K | 131K | 191K | 191K | 160K | 117K | 67K | 68.95K | 38.23K | 19.54K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 94.39M | 98.21M | 103.19M | 111.98M | 110.11M | 101.37M | 96.36M | 85.68M | 87.53M | 89.92M | 87.67M | 88.65M | 97.26M | 93.79M | 89.95M | 79.05M | 66.96M | 69.16M |
Income Tax Expense | -681K | -681K | n/a | n/a | n/a | n/a | -1.68M | -3.12M | -3.31M | -3.22M | -1.61M | -176K | -232.33K | -274.01K | -226.47K | -336.82K | -565.5K | -2.19M |
Shares Outstanding (Basic) | 81.48M | 75.55M | 71.26M | 71.08M | 70.92M | 70.8M | 58.25M | 53.63M | 50.69M | 50.13M | 50.03M | 48.99M | 47.5M | 43.97M | 41.71M | 41.37M | 41.36M | 38.91M |
Shares Outstanding (Diluted) | 81.48M | 75.55M | 71.26M | 71.08M | 70.92M | 70.8M | 58.44M | 53.63M | 50.69M | 50.13M | 50.03M | 49.29M | 47.5M | 43.97M | 41.71M | 41.37M | 41.36M | 38.91M |
EPS (Basic) | -1.18 | -1.26 | -1.34 | -1.55 | -1.62 | -1.59 | -1.62 | -1.48 | -1.57 | -1.67 | -1.74 | -1.91 | -2.24 | -2.42 | -2.36 | -2.06 | -1.79 | -2.13 |
EPS (Diluted) | -1.18 | -1.26 | -1.34 | -1.55 | -1.62 | -1.59 | -1.62 | -1.48 | -1.57 | -1.67 | -1.74 | -1.91 | -2.24 | -2.42 | -2.36 | -2.06 | -1.79 | -2.13 |
EBITDA | -89.1M | -90.75M | -94.81M | -101.42M | -99.14M | -90.62M | -86.76M | -80.11M | -83.23M | -87.16M | -85.98M | -86.44M | -96.17M | -100.91M | -96.44M | -83.53M | -68.34M | -61.88M |
EBIT | -88.16M | -90.91M | -95.05M | -103.51M | -101.31M | -92.73M | -88.41M | -78.62M | -81.62M | -85.61M | -84.9M | -87.01M | -96.84M | -101.6M | -97.08M | -83.86M | -68.64M | -62.17M |
Depreciation & Amortization | 129K | 160K | 238K | 2.1M | 2.17M | 2.23M | 1.77M | -354K | -612K | -680K | -205K | 362.38K | 610.02K | 632.11K | 587.41K | 335.15K | 301.4K | 299K |